Stocks · Health care · Biological Products, (No Diagnostic Substances)

Editas Medicine, Inc.

EDIT Clue Score47

United States Fiscal year ends December CIK 0001650664 Results filed 5 Aug 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Jessica Hopfield

13 May 2024

Director

Buy

45,000

$5.64

$253.87K

Jessica Hopfield

3 Mar 2021

Director

Buy

5,800

$45.51

$263.97K

James C Mullen

2 Mar 2021

CEO

Buy

25,000

$46.27

$1.16M

Jessica Hopfield

5 Mar 2019

Director

Buy

10,200

$23.94

$244.19K

James C Mullen

18 May 2018

Director

Buy

10,000

$38.03

$380.25K

Jessica Hopfield

17 May 2018

Director

Buy

6,700

$37.28

$249.78K

Boris Nikolic

2 Jun 2017

Director

Buy

35,000

$14.07

$492.53K

Gerald Frank Cox

2 Jun 2017

Chief Medical Officer

Buy

4,000

$14.15

$56.60K

Show all 225 transactions →

What was left out

Form 4 filings counted 275

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 6

Sales on a Rule 10b5-1 plan 48

Sales straight out of an exercise 63

Sales at will 106

Transactions with no price 0

Shares from compensation/vesting 1,580,660

Sales filed before the plan box existed 106

History held since 4 Feb 2016